241 related articles for article (PubMed ID: 25780876)
1. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
[TBL] [Abstract][Full Text] [Related]
3. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
4. Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
Venkatesan G; Paira P; Cheong SL; Vamsikrishna K; Federico S; Klotz KN; Spalluto G; Pastorin G
Bioorg Med Chem; 2014 Mar; 22(5):1751-65. PubMed ID: 24518296
[TBL] [Abstract][Full Text] [Related]
5. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
[TBL] [Abstract][Full Text] [Related]
8. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
El-Tayeb A; Gollos S
Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
[TBL] [Abstract][Full Text] [Related]
10. 7-Amino-2-aryl/hetero-aryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and adenosine receptor binding studies.
Shaik K; Deb PK; Mailavaram RP; Chandrasekaran B; Kachler S; Klotz KN; Jaber AMY
Chem Biol Drug Des; 2019 Aug; 94(2):1568-1573. PubMed ID: 30985956
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A
Fuentes E; Fuentes M; Caballero J; Palomo I; Hinz S; El-Tayeb A; Müller CE
Platelets; 2018 May; 29(3):292-300. PubMed ID: 28504052
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
Lee S; Nivedha AK; Tate CG; Vaidehi N
Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
[TBL] [Abstract][Full Text] [Related]
14. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update.
Guerrero A
Curr Med Chem; 2018; 25(30):3597-3612. PubMed ID: 29532748
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor as a drug discovery target.
de Lera Ruiz M; Lim YH; Zheng J
J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
18. Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.
Park HM; Lee JH; Yaoyao J; Jun HJ; Lee SJ
Biochem Biophys Res Commun; 2011 Jan; 404(1):345-8. PubMed ID: 21134357
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling.
Bharate SB; Singh B; Kachler S; Oliveira A; Kumar V; Bharate SS; Vishwakarma RA; Klotz KN; Gutiérrez de Terán H
J Med Chem; 2016 Jun; 59(12):5922-8. PubMed ID: 27227326
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
